Inogen/INGN

$8.10

-5.81%
-
1D1W1MYTD1YMAX

About Inogen

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.

Ticker

INGN

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Kevin Smith

Employees

834

Headquarters

Goleta, United States

Inogen Metrics

BasicAdvanced
$203M
Market cap
-
P/E ratio
-$4.15
EPS
1.09
Beta
-
Dividend rate
$203M
1.0874
$11.98
$4.13
371K
2.695
2.362
-27.57%
-40.86%
-34.28%
0.631
1.055
1.359
-12.87%
-5.99%
0.77%

What the Analysts think about Inogen

Analyst Ratings

Majority rating from 4 analysts.
Hold

Price Targets

Average projection from 2 analysts.
13.58% downside
High $7.00
Low $7.00
$8.10
Current price
$7.00
Average price target

Inogen Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-18.58% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$78M
2.9%
Net income
-$15M
-45.28%
Profit margin
-18.58%
-46.85%

Inogen Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 18.21%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.42
-$1.97
-$1.14
-$0.62
-
Expected
-$0.59
-$0.49
-$0.63
-$0.76
-$0.55
Surprise
-29.27%
300%
82.4%
-18.21%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Inogen stock?

Inogen (INGN) has a market cap of $203M as of May 30, 2024.

What is the P/E ratio for Inogen stock?

The price to earnings (P/E) ratio for Inogen (INGN) stock is 0 as of May 30, 2024.

Does Inogen stock pay dividends?

No, Inogen (INGN) stock does not pay dividends to its shareholders as of May 30, 2024.

When is the next Inogen dividend payment date?

Inogen (INGN) stock does not pay dividends to its shareholders.

What is the beta indicator for Inogen?

Inogen (INGN) has a beta rating of 1.09. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Inogen stock price target?

The target price for Inogen (INGN) stock is $7, which is 13.58% below the current price of $8.1. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Inogen stock

Buy or sell Inogen stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing